Immunodiscordant responses to HAART – mechanisms and consequences
Authors:
- Marta MassanellaMMMarta Massanella
- Eugènia NegredoENEugènia Negredo
- Bonaventura ClotetBCBonaventura Clotet
- Julià BlancoJBJulià Blanco
- 1 November 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 9 (11) , 1135-1149
Abstract
A relevant fraction of HIV-1-infected individuals (ranging from 15 to 30%) presenting virologically successful highly active antiretroviral therapy fail to recover CD4 T-cell counts. These individuals, called immunodiscordant or immunological nonresponders, are at increased risk of clinical progression and death. Although older age, lower nadir CD4 T-cell count and HCV co-infection are some of clinical predictive factors, immunological mechanisms rely on impaired thymic production and accumulation of apoptosis-prone CD4 T cells. Indeed, immunodiscordant individuals may show increased tissue fibrosis and damage of gut-associated lymphoid tissue that results in higher hyperactivation, inflammation and immunosenescence, altered Treg/Th17 ratio and increased T-cell death. A better knowledge of the final pathogenic mechanism and factors influencing CD4 T-cell recovery will help to select the optimal therapeutic strategies for them.Keywords
This publication has 120 references indexed in Scilit:
- Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral TherapyThe Journal of Infectious Diseases, 2010
- Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defectsProceedings of the National Academy of Sciences, 2009
- Interleukin-2 Therapy in Patients with HIV InfectionNew England Journal of Medicine, 2009
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patientsClinical Science, 2009
- HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cellsProceedings of the National Academy of Sciences, 2008
- Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2008
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2008
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006